TY  - CONF

T1  - IMMUNO-MODULATION IN AMYOTROPHIC LATERAL SCLEROSIS - A PHASE II STUDY OF SAFETY AND ACTIVITY OF LOW DOSE INTERLEUKIN-2 (IMODALS study) (S3.006)

JO  - Neurology

UR  - https://doi.org/10.1212/wnl.88.16_supplement.s3.006

PY  - 2017/04/18

AU  - Bensimon G

AU  - Camu W

AU  - Payan C

AU  - Tree T

AU  - Veyrune J-L

AU  - Malaspina A

AU  - Garlanda C

AU  - Locati M

AU  - Saker S

AU  - Juntas-Morales R

AU  - Pageot N et al

ED  - 

DO  - DOI: 10.1212/wnl.88.16_supplement.s3.006

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 88

IS  - 16_supplement

Y2  - 2025/11/22

ER  -